The Possibility Of A Three-Parent Baby
By Indira Lakshamanan,
The Diane Rehm Show
| 02. 25. 2016
[cites CGS' Marcy Darnovsky]
Untitled Document
Researchers are now capable of creating a human embryo from the DNA of three people. A scientific panel recently concluded it is ethically permissible to pursue further research – aimed at helping women with defective genes produce healthy babies. Others oppose the panel’s findings, saying the risks are too great. They’re concerned new genetic material might inadvertently create diseases that could be passed down for generations. And some view it as an unwelcome step toward creating designer babies. The FDA is reviewing the panel’s report, but is not allowed to approve new research at present. A discussion about the science, ethics and politics of three-person embryos.
Guests
- Jeffrey Kahn professor of bioethics and public policy, Johns Hopkins Berman Institute of Bioethics.
- Dieter Egli assistant professor of developmental cell biology, Department of Pediatrics, Columbia University
- Marcy Darnovsky executive director, Center for Genetics and Society
- Sarah Karlin health care reporter, Politico
Transcript of Radio Show ...
Image via YouTube
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...